The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the ...

SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...

Sutter Health will be the first healthcare system in the Sacramento area to offer SAINT, a new accelerated version of ...

PANAMA CITY, Fla. (WJHG/WECP) - After 20 years of service, one panhandle veteran found himself in a different kind of fight-- one for his mental health. But a noninvasive treatment is helping him ...

Real-world evidence supporting the expanded approval demonstrated a 66.1% response rate in adolescents with major depressive disorder. The Food and Drug Administration (FDA) has cleared BrainsWay’s ...

Unlike commonly used oral antidepressants (often known as selective serotonin reuptake inhibitors or SSRIs), ketamine works through a different mechanism. It targets glutamate pathways in the brain, ...

In what's being signaled as a beacon of hope for adolescents fighting the sullen clouds of severe depression, the FDA has greenlit a new device that might just alter the landscape of treatment for ...

BOSTON, Oct. 13, 2025 /PRNewswire/ -- Zeta Surgical today announced that its Zeta TMS Navigation System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The device is ...